The negative effect of senescent cells and targeted treatments for

osteoarthritis and aging

MONDAY, 08 MAY 2017

The negative effect of senescent cells and targeted treatments for osteoarthritis and aging

Cellular Senescence is a state of cells where cells stop taking an active dividing role in the tissue, but at the same time refuse to react to the natural signals to apoptosis (“cellular suicide”). This state does not only leave them as useless and inactive cells, but they also secrete substances (cytokines and extracellular vesicles) which scientists now know have negative effects. This secretion became infamous under the “Senescence Associated Secretory Phenotype (SASPs)”. More than just a negative stimuli for all surrounding cells and the immune system, the state of senescence and SASPs are now regarded as one of the pillars of aging itself, possibly even the single most important one. Enough senescent cells will kill you, but the more common mechanism is that they induce age-related fatal diseases which then end life (if no other cause of death occurs).

Osteoarthritis (OA) effects large parts of the population. It is one of the main causes of pain and disability in our aging population. Classified as a chronic inflammatory disease, the mystery in OA was where the inflammatory molecules were coming from. New work published in the journal Nature Medicine brings at least partialy an answer to this question. The main driving factors for OA appear to be senescent cells and their SASPs. In their study, they could show that clearance of these cells can potentially result in significant and life long lasting improvement in a mouse model even after a single injection.

There are a few types of new drug candidates to induce senescent cell clearing. They range from nutrition supplements (Quercitin), particular chemotherapeutic agents and experimental small molecules (ABT263). But also gene therapeutic approaches and designed specific peptides are among the candidates for as a senescent cell clearing substance.

In another Nature Paper, the regenerative factors for the Stem Cell Secretome, namely extracellular vesicles, is described. In combination, senescent cell clearing followed by the proliferation inducing paracrine effects of the Stem Cell Secretome are likely to fundamentally change the way medicine think about and treat OA.

Links:

Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment


Extracellular vesicles — new tool for joint repair and regeneration


News & Insights

Stem Cell Therapy for Enhancement of Saliva Production

ANOVA Dry Mouth

ANOVA Institute for Regenerative Medicine is partnering with experts at Copenhagen Stem to help patients with Dry Mouth Syndrome to regenerate their salivary gland function with Stem Cell Therapy. Read more.

Infusion Therapy as a Treatment Addition

ANOVA Infusion therapy header

Infusion Therapy is a way to administer medication, vitamins, nutrients and other molecules into the body, by using a sterile catheter that is inserted into a vein. It is an alternative to oral treatment, and can be the fastest way to deliver these vital compounds into your body. Read more.

Rehabilitation and Physiotherapy

Rehabilitation

The human body consists of several complex functional systems encompassing the brain, spinal cord, peripheral nerves and bones and muscles, among others. The damage of one of these units can cause the whole system to fail. Read more.

Stem Cell Secretome as an Emerging Treatment for Parkinson’s Disease

AdobeStock 205994966

Parkinson's Disease (PD) is a chronic nervous system disorder that affects the patient’s movement. Symptoms will usually start gradually, with tremors being the most common symptom, but the disorder can also cause stiffness or slowed down movement. Read more.

ANOVA now offers Platelet-Rich Plasma (PRP) for Orthopedic Treatments

AdobeStock 176004115

ANOVA Institute for Regenerative Medicine is now offering Platelet-Rich Plasma (PRP) on its own or in combination with other therapies such as Bone Marrow Concentrate (BMC) or hyaluronic acid for the effective treatment of different orthopedic problems. Read more.

Copyright © ANOVA Institute for Regenerative Medicine GmbH 2019. All Rights reserved. | Privacy Police